Your browser doesn't support javascript.
loading
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation.
Kozak, Rouba; Kiss, Tamás; Dlugolenski, Keith; Johnson, David E; Gorczyca, Roxanne R; Kuszpit, Kyle; Harvey, Brian D; Stolyar, Polina; Sukoff Rizzo, Stacey J; Hoffmann, William E; Volfson, Dmitri; Hajós, Mihaly; Davoren, Jennifer E; Abbott, Amanda L; Williams, Graham V; Castner, Stacy A; Gray, David L.
Afiliación
  • Kozak R; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Kiss T; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Dlugolenski K; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Johnson DE; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Gorczyca RR; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Kuszpit K; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Harvey BD; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Stolyar P; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Sukoff Rizzo SJ; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Hoffmann WE; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Volfson D; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Hajós M; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Davoren JE; Department of Comparative Medicine, Yale School of Medicine, New Haven, CT, United States.
  • Abbott AL; Global Research and Development, Pfizer Inc., Groton, CT, United States.
  • Williams GV; Department of Comparative Medicine, Yale School of Medicine, New Haven, CT, United States.
  • Castner SA; Department of Comparative Medicine, Yale School of Medicine, New Haven, CT, United States.
  • Gray DL; Department of Comparative Medicine, Yale School of Medicine, New Haven, CT, United States.
Front Pharmacol ; 11: 1005, 2020.
Article en En | MEDLINE | ID: mdl-32733245

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos